ARRAY BIOPHARMA, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07D HETEROCYCLIC COMPOUNDS 15347
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 137124
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 2570
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 2228
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 6132
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 5120
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 466
 
  
 
C30B SINGLE-CRYSTAL GROWTH 353
 
  
 
C07K PEPTIDES 2134
 
  
 
C04B LIME; MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS 167

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0260,589 POINT MUTATIONS IN TRK INHIBITOR-RESISTANT CANCER AND METHODS RELATING TO THE SAMEOct 26, 16Sep 14, 17[A61K, C12Q]
2017/0252,317 N4-PHENYL-QUINAZOLINE-4-AMINE DERIVATIVES AND RELATED COMPOUNDS AS ERBB TYPE I RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASESMay 19, 17Sep 07, 17[A61K, C07D]
2017/0172,988 METHOD OF TREATMENT USING INHIBITORS OF MITOSISDec 28, 16Jun 22, 17[A61K]
2017/0136,022 SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITORSep 23, 16May 18, 17[A61K]
2017/0096,425 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORSJul 15, 16Apr 06, 17[A61K, C07D]
2017/0087,156 1-((3S,4R)-4-(3-FLUOROPHENYL)-1-(2-METHOXYETHYL)PYRROLIDIN-3-YL)-3-(4-METHYL-3-(2-METHYLPYRIMIDIN-5-YL)-1-PHENYL-1H-PYRAZOL-5-YL)UREA AS A TRKA KINASE INHIBITORMay 14, 15Mar 30, 17[A61K, C07D]
2016/0280,686 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORSJun 10, 16Sep 29, 16[C07D]
2016/0280,687 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORSJun 10, 16Sep 29, 16[C07D]
2016/0200,723 PROCESS FOR PREPARING A COMPOUNDAug 21, 14Jul 14, 16[C07D]
2015/0110,780 TREATMENT OF BRAIN CANCERMar 25, 13Apr 23, 15[A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9902741 Macrocyclic compounds as TRK kinase inhibitorsJun 23, 17Feb 27, 18[C07D]
9896435 N-pyrrolidinyl,N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitorsNov 12, 13Feb 20, 18[C07D]
9889134 Polymorphs of ARRY-380, a selective HER 2 inhibitor and pharmaceutical compositions containing themOct 26, 15Feb 13, 18[A61K, C07D, A61P]
9878997 Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsDec 16, 16Jan 30, 18[C07D]
9850229 Compounds and compositions as protein kinase inhibitorsJun 10, 16Dec 26, 17[A61K, C07D]
9850230 Compounds and compositions as protein kinase inhibitorsJun 10, 16Dec 26, 17[A61K, C07D]
9840519 Macrocyclic compounds as TRK kinase inhibitorsNov 14, 16Dec 12, 17[C07D]
9828360 Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitorsNov 13, 13Nov 28, 17[C07D]
9822118 Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitorsNov 13, 13Nov 21, 17[C07D]
9809578 Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trkA kinase inhibitorsNov 13, 13Nov 07, 17[C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0251,350 CRYSTALLINE FORMS OF A PYRROLOPYRIDINE COMPOUNDAbandonedFeb 26, 16Sep 01, 16[A61K, C07D]
2016/0235,754 HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORSAbandonedApr 28, 16Aug 18, 16[A61K]
2016/0152,576 AKT PROTEIN KINASE INHIBITORSAbandonedJan 31, 14Jun 02, 16[C07D]
2016/0137,608 SUBSTITUTED BENZOAZEPINES AS TOLL-LIKE RECEPTOR MODULATORSAbandonedOct 13, 15May 19, 16[C07D]
2016/0137,654 CRYSTALLINE FORM OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE HYDROGEN SULFATEAbandonedNov 16, 15May 19, 16[C07D]
2015/0299,182 CRYSTALLINE FORMS OF (1S)-1-[5-(AMINO)-1,2,4-THIADIAZOL-3-YL]ETHANE-1,2-DIOLAbandonedNov 08, 13Oct 22, 15[C07D]
2015/0231,117 ARRY-520 FOR USE IN TREATING CANCER IN A PATIENT WITH LOW AAGAbandonedAug 13, 13Aug 20, 15[A61K, G01N]
2015/0191,479 DIHYDROFURO PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORSAbandonedOct 16, 14Jul 09, 15[A61K, C07D]
2015/0045,391 FILANESIB COMBINED WITH POMALIDOMIDE DISPLAYS ENHANCED ANTI-TUMOR ACTIVITYAbandonedAug 07, 14Feb 12, 15[A61K]
2014/0315,887 PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORSAbandonedJul 01, 14Oct 23, 14[C07D]
2014/0309,226 PIPERIDINYL-SUBSTITUTED CYCLIC UREAS AS GPR119 MODULATORSAbandonedNov 14, 12Oct 16, 14[C07D]
2014/0256,756 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORSAbandonedOct 30, 12Sep 11, 14[C07D]
2014/0228,349 5,7-SUBSTITUTED-IMIDAZO[1,2-C]PYRIMIDINESAbandonedOct 09, 12Aug 14, 14[C07D]
2014/0221,370 PYRROLOPYRIDINES AS KINASE INHIBITORSAbandonedApr 09, 14Aug 07, 14[A61K, C07D]
2014/0221,443 NOVEL HYDROGEN SULFATE SALTAbandonedJan 10, 14Aug 07, 14[C07D]
2014/0018,399 MITOTIC KINESIN INHIBTORS AND METHODS OF USE THEREOFAbandonedSep 19, 13Jan 16, 14[C07D]
2013/0195,971 PHARMACEUTICAL COMPOSITION 271AbandonedJan 23, 13Aug 01, 13[A61K]
2013/0184,257 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORSAbandonedSep 15, 11Jul 18, 13[C07D]
2013/0065,908 DIHYDROFURO PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORSAbandonedNov 08, 12Mar 14, 13[A61K, C07D, A61P]
8394795 Pyrazole [3, 4-B] pyridine Raf inhibitorsExpiredFeb 27, 09Mar 12, 13[A61K, C07D]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.